Progestogen-Only Contraceptives Linked to Higher Risk of Breast Cancer
Researchers found a similarly increased risk of breast cancer for progestogen-only contraceptives and oral combined contraceptives.
Researchers found a similarly increased risk of breast cancer for progestogen-only contraceptives and oral combined contraceptives.
Mammography use is still higher among White patients than among American Indian patients, but the gap is narrowing due to declining mammography use in White patients.
Military pilots and the ground crews who fuel and maintain their aircraft have higher rates of certain cancers, a new study shows.
Adolescent and young adult patients diagnosed with cancer during pregnancy have a higher risk of adverse birth outcomes, a study suggests.
Among African-American cancer survivors, experiencing discrimination is associated with frailty, a study suggests.
Low-dose tamoxifen reduces the risk of breast cancer among patients with intraepithelial neoplasia for several years, data suggest.
Researchers are conducting a phase 2 trial to test pembrolizumab and tamoxifen, with or without vorinostat, in patients with ER+ breast cancer.
Researchers are testing valemetostat plus trastuzumab deruxtecan in patients with HER2-low/ultra-low/null metastatic breast cancer.
Researchers are conducting a phase 1b/2 trial to test tucatinib plus alpelisib in patients with advanced, PIK3CA-mutant, HER2+ breast cancer.
Researchers are conducting a phase 1 trial to test CAR T-cell therapy in patients with mesothelin-expressing triple-negative breast cancer.